跳至主要内容
临床试验/KCT0004548
KCT0004548尚未招募未知

Safety and Efficacy of high dose inorganic seLenium for preventing chemotherapy induced pEripheral Neuropathy in platINUM sensitive recurrent ovarian, fallopian, primary peritoneal cancer: phase III randomized controlled trial (SELENIUM trial)

Seoul National University Hospital0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 80(Year)(—)
性别
Female

入选标准

  • (1) Informed consent
  • (2) Age: 19-80 years old
  • (3) Complete or partial response according to Response Evaluation Criteria In Solid Tumors (RECIST) or Gynecologic Cancer Intergroup criteria in epithelial ovarian cancer, fallopian cancer, or primary peritoneal cancer patients who underwent either surgery or chemotherapy and those who have recurred cancer at least six months after chemotherapy.
  • (4) Patients who have received paclitaxel chemotherapy for a minimum of 6 cycles and a maximum of 9 cycles
  • (5) ECOG performance status 0-2
  • (6) Patients with no other concurrent disease affecting overall survival
  • (7) Patients with normal hematologic, renal, and liver functions
  • (8) Patients who understand the contents of the clinical trial and are capable of participating until the end of the trial

排除标准

  • (1) Pregnancy or breastfeeding
  • (2) Patients diagnosed with recurrent ovarian cancer, fallopian cancer, or primary peritoneal cancer who received secondary debulking surgery.
  • (3) Patients diagnosed with recurrent ovarian cancer, fallopian cancer, or primary peritoneal cancer who did not receive Bevacizumab chemotherapy
  • (4) Patients with other concurrent disease that can affect overall survival (infection, hypertension, diabetes, cardiac disease, etcetera)
  • (5) Patients with underlying disease (diabetes, neuropathy, brain or bone metastasis) that can induced neuropathy
  • (6) Patients allergic to selenium
  • (7) Inappropriate patients by the researcher's decision

研究者

相似试验

招募中
3 期
effect of selenium on oxidative stress status and inflammatory factors in post gastrointestinal surgery childreCongenital diaphragmatic herniaCondition 1: Digestive System Surgical Procedures. Condition 2: selenium deficiency. Condition 3: Congenital diaphragmatic hernia. Condition 4: Acute abdomen. Condition 5: Congenital malformations of esophagus. Condition 6: Other specified congenital malformations of upper alimentary tract. Condition 7: Congenital disorders of small intestine. Condition 8: Congenital disorders of large intestine. Condition 9: Congenital malformations of gallbladder, bile ducts and liver.Unspecified intestinal obstructionSequelae of other nutritional deficienciesAcute abdomenCongenital malformations of esophagusOther congenital malformations of upper alimentary tractCongenital absence, atresia and stenosis of small intestineCongenital absence, atresia and stenosis of large intestineCongenital malformations of gallbladder, bile ducts and liverK56.60
IRCT20190122042449N1Mashhad University of Medical Sciences70
进行中(未招募)
3 期
High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral NeuropathyChemotherapy-induced Peripheral NeuropathyRecurrent Ovarian CarcinomaFallopian Tube CancerOvarian CancerPrimary Peritoneal Carcinoma
NCT04201561Seoul National University Hospital68
尚未招募
3 期
Investigation of the effect of selenium on the treatment of patients undergoing coronary artery bypass surgery with a pumpCoronary Artery Bypass Graft Surgery.Other mechanical complication of coronary artery bypass graft, subsequent encounterT82.218D
IRCT20220614055165N1Ghoum University of Medical Sciences70
招募中
1 期
Evaluation of Selenium coated lensesContact lens wearEye - Normal eye development and function
ACTRN12606000298516Institute for Eye Research180
招募中
3 期
The effect of selenium consumption in patients undergoing CABG surgeryCoronary Artery Bypass Grafting.Atherosclerosis of coronary artery bypass graft(s) and coronary artery of transplanted heart with angina pectorisI25.7
IRCT20150725023332N2Shahid Beheshti University of Medical Sciences80